Jeffrey Schwaneke, Chief Financial Officer and Interim Co-Principal Executive Officer at agilon health, inc.. Biography, career history and compensation sourced from agilon health, inc. SEC filings and official company website.
About
Jeffrey Schwaneke has served as agilon health's Chief Financial Officer since July 2024 and as co-Interim Principal Executive Officer since July 2025, as part of the Office of the Chairman. He previously served as a member of agilon's Board of Directors from 2022 to 2024. Before joining agilon, Mr. Schwaneke spent more than a decade at Centene Corporation, where he served as Executive Vice President of Health Care Enterprises in 2021 and as Executive Vice President, Chief Financial Officer and Treasurer from 2016 to 2021, having joined Centene in 2008 as Senior Vice President, Corporate Controller and Chief Accounting Officer. Earlier he was Assistant Controller and then Chief Accounting Officer of Novelis, Inc. He holds a B.S. in Accounting from the University of Missouri and is a CPA.
Roles
agilon health, inc.
Chief Financial Officer and Interim Co-Principal Executive Officer · Current role
2024–present
agilon health, inc.
Member of the Board of Directors
2022–2024
Centene Corporation
Executive Vice President of Health Care Enterprises · June to September 2021
—
Centene Corporation
Executive Vice President, Chief Financial Officer and Treasurer · March 2016 to May 2021
2016–2021
Centene Corporation
Senior Vice President, Corporate Controller and Chief Accounting Officer · Joined July 2008
—
Novelis, Inc.
Assistant Controller; then Chief Accounting Officer
2006–2008
SPX
Senior finance position
—
PwC (Price Waterhouse)
Senior finance position
—
Fixed Compensation
FY 2025
Base salary
$625,000
ComponentAnnual base salary
All other compensation
$14,000
IncludesIncludes a $300,000 signing bonus in 2024 (none in 2025)
Total compensation
$5,610,878
Performance Compensation
Data from FY 2025
Cash incentive
Annual cash incentive
$271,875
FormNon-Equity Incentive Plan Compensation
Stock awards
Stock awards
$2,950,003
FormRSUs and PSUs (grant date fair value, ASC 718)